X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

INAB

Closed

In8bio inc

2.07
-0.02 (-0.96%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.09
Day's Range: 2.06 - 2.135
Send
When Written:
 
1.28
In8bio Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of innovative therapies for the treatment of cancer and other diseases. The company's proprietary platform technology, called Gamma Delta T cell engager, is designed to harness the power of the body's immune system to target and destroy cancer cells. In8bio's pipeline includes several product candidates in various stages of development, including INB-200, which is being evaluated in a Phase 1 clinical trial for the treatment of solid tumors. The company was founded in 2016 and is headquartered in New York City.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X